Differential effect of estrogen on the production of cyclin B1, cdc2 p34 and c-fos protein in rat uterus.
The uterine content of c-fos protein, cyclin B1 (cell cycle protein) and cdc2 p34(cyclin-dependent kinase) in immature and mature rats was determined using the enhanced chemiluminescence(ECL) western blot method. Cyclin B1 was found predominantly in immature rat uterus and cdc2 p34 only in mature rat uterus. Several isoforms of c-fos oncogene protein were present in both mature and immature rat uteri. An additional immunoreactive c-fos protein with an estimated molecular weight of 28 kDa was found in mature rat uterus and was missing in immature uterus. Uteri from ovariectomized rats treated with estrogen and/or ICI 182,780, an antiestrogen, were analyzed by ECL western blot. cdc2 p34 and the c-fos 28 kDa protein were found in estradiol-treated rat uteri and were not detected in uteri of control and ICI 182,780-treated animals; whereas Cyclin B1 was absent in uteri from control and estradiol-treated ovariectomized animals. ICI 182,780 administered to estradiol-treated ovariectomized rats blocked the induction of cdc2 p34 and the c-fos 28 kDa protein in the uterus. The present results show that the production of the cell cycle factors, cyclin B1, cdc2 p34 and c-fos, during rat uterine growth are under different regulatory controls. cdc2 p34 and c-fos 28 kDa protein are under the control of estradiol; whereas cyclin B1 and the majority of the immunoreactive isoforms of c-fos are not influenced by this hormone.
Yang
L S
LS
Center for Biomedical Research, Population Council, New York, NY 10021.
Marshall
A
A
Koide
S S
SS
D000818:Animals; D000906:Antibodies; D016203:CDC2 Protein Kinase / Q000096:biosynthesis / Q000187:drug effects; D018797:Cell Cycle Proteins / Q000032:analysis / Q000187:drug effects*; D016213:Cyclins / Q000096:biosynthesis / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D000077267:Fulvestrant; D010052:Ovariectomy; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis / Q000096:biosynthesis* / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D014599:Uterus / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology*
D000906:Antibodies; D018797:Cell Cycle Proteins; D016213:Cyclins; D004965:Estrogen Antagonists; D016760:Proto-Oncogene Proteins c-fos; D000077267:Fulvestrant; D004958:Estradiol; D016203:CDC2 Protein Kinase